-
Thomson American Health Consultants offers "Extended-use Contraception: What You Should Know About Seasonale and Other Options," a free audio conference on October 9 from 2-3 p.m. ET.
-
In 1597, the herbalist John Gerard reported that an extract of the sage plant, is singularly good for the head and brain and quickeneth the nerves and memory. More than 400 years later, British investigators have put Gerards observation to the test by examining the effects of an essential oil derived from Spanish sage on memory in normal volunteers and patients with Alzheimers disease.
-
The triptan wars are heating up with 7 competitors now on the market all backed by the heaviest of the pharma heavyweights, and clinicians wonder, Which is the best triptan? This study looked at eletriptan response rates in a cohort of migraine patients previously unresponsive or intolerant to sumatriptan.
-
When is it safe to sit behind the wheel if youve just had a seizure? In this time-trend study, an analysis was undertaken to determine if lowering the interval from 12 months to 3, as was done in Arizona, increased motor vehicle accident frequency.
-
In the present article, Thomalla and colleagues report on the predictive value of early perfusion-weighted magnetic resonance imaging and diffusion-weighted magnetic resonance imaging within 6 hours of stroke onset in 37 patients with MCA stroke and a proximal vessel occlusion, either the carotid-T or MCA stem.
-
The FDA has approved vardenafil (LevitraBayer and GlaxoSmithKline) for
the treatment of erectile dysfunction in men. Vardenafil joins
sildenafil (Viagra) as the only 2 drugs approved for this indication in
this country.
-
A Strategy to Reduce Cardiovascular Disease by More Than 80 Percent;
Pearly Penile Papules: Still No Reason for Uneasiness; The Epidemiology
of Major Depressive Disorder; Urinary Tetrahydroaldosterone as a Screen
for Aldosteronism; Finasteride and Prostate Cancer; Impermeable Bed
Covers in Patients with Allergic Rhinitis
-
Seasonale (Barr Laboratories, Pomona, NY), the first extended-cycle oral contraceptive (12 weeks continuous daily active pill followed by a one-week inactive pill) approved by the Food and Drug Administration (FDA) is expected to become clinically available by the end of this month.
-
ACNM web site offers breast-feeding resources; New condom now available from Trojan; New Arabic web site offers EC information
-
Just six years ago, a national report asked, Is the secret getting out? when it comes to emergency contraception (EC).1 If results of the 2003 Contraceptive Technology Update Contraception Survey are any indication, ECs message now is being heard loud and clear.